US-based private equity firm Advent International has agreed to invest Rs 2,475 crore ($296 million) to pick up a minority stake in Apollo HealthCo Ltd, ..
"A number of factors confluence to make India a pharmaceutical powerhouse, some of them being the regulatory framework, lower production costs, and the skilled pool of manpower comprising scientists, researchers, engineers and professionals," said Chintan Haria.
Indian shares traded lower on Friday to extend losses for a fifth day running as U.S. rate worries lingered and oil prices jumped more than 3 percent on signs of escalating tensions in the Middle East, following reports of Israeli strikes on Iran.
Corporate India is starting to step up its capital expenditure plans amid government incentives and signs of rising demand, company executives and analysts have indicated.
This coincides with the Reserve Bank of India (RBI) recently citing a double-digit growth in private capital expenditure.
Healthy balance sheets of banks and corporates, along with increasing capacity utilisation and improving business sentiment, are contributing to a favourable environment for sustained growth in private sector investments, the RBI said in its policy last week.